Final report from the analysis of candidate gene markers and genome-wide single nucleotide polymorphisms (SNPs) from two retrospective, case-control studies and three controlled clinical studies to investigate genetic polymorphisms in HIV infected subjects who developed hypersensitivity following treatment with abacavir

Trial Profile

Final report from the analysis of candidate gene markers and genome-wide single nucleotide polymorphisms (SNPs) from two retrospective, case-control studies and three controlled clinical studies to investigate genetic polymorphisms in HIV infected subjects who developed hypersensitivity following treatment with abacavir

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2007

At a glance

  • Drugs Abacavir (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Pharmacogenomic
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top